AllQuantitative Report
logoArgusOctober 15, 2020

XNCR: Lowering target price to $43.00

Symbols
XNCR
Sector(s)
Healthcare
Rating
Premium
Current Price
$40.97
Price Target
$NaN
Earnings Estimate
Premium
Summary

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE